Chen Yong, Weng Chengyin, Zhang Hui, Sun Jianqun, Yuan Yawei
Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Department of Oncology and Hematology, The Central Hospital of Shaoyang, Shaoyang, China.
Cell Physiol Biochem. 2018;47(6):2350-2359. doi: 10.1159/000491607. Epub 2018 Jul 10.
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. DNA damage repair in cancer cells is a promising approach for the treatment of cancers. We aimed to explore the potential interaction between p53-binding protein 1 (53BP1) and minichromosome maintenance (MCMs) proteins during DNA damage in human hepatoma HepG2 cells.
The recombinant vectors of 53BP1 and MCMs with tags were constructed and transfected into HepG2 cells. Immunoprecipitation (IP) and mass spectrometry (MS) were performed to identify the possible interactions between 53BP1 and MCMs, and glutathione S-transferase (GST) pull-down assay was carried out to detect the direct interaction. Moreover, the expressions of MCM2 and MCM6 were suppressed by specific short hairpin RNAs (shRNAs), and then the chromatin fraction and foci formation of 53BP1 were examined under the condition of DNA damage.
The results showed that MCM2/3/5/6 was immunoprecipitated against the hemaglutinin (HA)-tagged 53BP1 in HepG2 cell nuclei. GST results revealed that there was a direct interaction between 53BP1 and MCMs complex. Moreover, the non-chromatin level of 53BP1 was significantly increased by down-regulation of MCM2 or MCM6, but was statistically decreased the chromatin level. Furthermore, we observed that knockdown of MCM2 or MCM6 could statistically inhibit the foci formation of 53BP1 in HepG2 cell nuclei upon bleomycin-induced DNA damage (P < 0.01).
Our results suggest that there is a direct interaction between 53BP1 and MCMs, which is essential for 53BP1 chromatin fraction and foci formation in hepatoma HepG2 cells.
背景/目的:肝细胞癌(HCC)是全球癌症相关死亡的第二大主要原因。癌细胞中的DNA损伤修复是一种很有前景的癌症治疗方法。我们旨在探讨人肝癌HepG2细胞DNA损伤过程中p53结合蛋白1(53BP1)与微小染色体维持(MCMs)蛋白之间的潜在相互作用。
构建带有标签的53BP1和MCMs重组载体并转染至HepG2细胞。进行免疫沉淀(IP)和质谱分析(MS)以鉴定53BP1与MCMs之间可能的相互作用,并进行谷胱甘肽S-转移酶(GST)下拉试验以检测直接相互作用。此外,用特异性短发夹RNA(shRNAs)抑制MCM2和MCM6的表达,然后在DNA损伤条件下检测53BP1的染色质组分和灶形成。
结果显示,在HepG2细胞核中,MCM2/3/5/6与血凝素(HA)标记的53BP1发生免疫沉淀。GST结果显示53BP1与MCMs复合物之间存在直接相互作用。此外,MCM2或MCM6的下调显著增加了53BP1的非染色质水平,但在统计学上降低了染色质水平。此外,我们观察到,在博来霉素诱导的DNA损伤后,敲低MCM2或MCM6可在统计学上抑制HepG2细胞核中53BP1的灶形成(P < 0.01)。
我们的结果表明53BP1与MCMs之间存在直接相互作用,这对于肝癌HepG2细胞中53BP1的染色质组分和灶形成至关重要。